# EnterpriseSynth: Outreach Materials

Ready-to-send emails and pitches for all external audiences.
Customize [bracketed fields] before sending.

---

## 1. Synthetic Data Vendor Outreach

### Gretel.ai

**To:** [developer-relations@gretel.ai or community lead via GitHub/LinkedIn]
**Subject:** *Independent benchmark inclusion for Gretel — EnterpriseSynth*

> Hi [Name],
>
> I'm reaching out from the EnterpriseSynth project — the first open benchmark
> for differential privacy synthetic data evaluation across regulated enterprise
> data types (GDPR/HIPAA/SOX). We're targeting NeurIPS 2026 D&B track and are
> building toward becoming the reference comparison that enterprise procurement
> teams cite.
>
> We'd like to include Gretel in our results, and here's what that looks like in practice:
>
> **What you do**: Run your ACTGAN or Navigator model against our enterprise schema corpus
> (HR records, financial transactions, healthcare EHR — ~500 records per schema) and report
> three metrics: membership inference AUC, TSTR F1, and constraint violation rate.
> The evaluation scripts are open-source at github.com/anote-ai/Research-EnterpriseSynth.
>
> **What you get**:
> - Listed in the NeurIPS paper's comparison table with your model name
> - A "Benchmark Participant" badge for your website and docs
> - Early access to full benchmark results before publication
> - A "Verified" label if results are independently confirmed (stronger than self-reported)
>
> **The ask**: ~2 hours of an ML engineer's time to run the eval protocol.
>
> Results are reported honestly — including unfavorable ones — but labeled clearly
> as "Self-Reported (Gretel AI)" vs. "Independently Verified." We don't hide bad results;
> we contextualize them. A vendor that publishes honestly gains credibility; one that
> cherry-picks does not.
>
> We're also open to co-hosting a webinar on the benchmark findings — "The State of
> Enterprise Synthetic Data" — which would give Gretel direct access to the compliance
> and healthcare audiences we're targeting.
>
> Would a 20-minute call this week work?
>
> Best regards,
> Rashmi Thimmaraju
> anote AI | github.com/anote-ai/Research-EnterpriseSynth

---

### Mostly AI

**To:** [via LinkedIn / hello@mostly.ai]
**Subject:** *Benchmark inclusion: EnterpriseSynth — independent evaluation for enterprise synthetic data*

> Hi [Name],
>
> I'm Rashmi Thimmaraju from anote AI, working on EnterpriseSynth — the first benchmark
> specifically covering differential privacy synthetic data for regulated enterprise settings
> (GDPR, HIPAA, SOX). We're targeting NeurIPS 2026 and building toward being the reference
> that compliance teams cite.
>
> Mostly AI's focus on enterprise customers is exactly the audience this benchmark is
> designed for. Including your results would:
> - Add credibility to the benchmark (major vendors participating = community acceptance)
> - Give Mostly AI a "Benchmark Participant" badge and paper citation
> - Position you in comparison with SDV and Gretel when compliance teams search for
>   independent comparisons
>
> The evaluation uses our published schemas and scripts; your ML team runs their
> model and submits a JSON results file. Total effort: ~2 hours.
>
> I'd also like to discuss the model collapse finding specifically — we show that
> iterative retraining depletes fraud/security records within 5 generations, which
> is a risk affecting all synthetic data pipelines. Mostly AI customers who do
> iterative retraining need to know about this.
>
> Can we set up a 20-min call to discuss?
>
> Rashmi Thimmaraju
> anote AI

---

### Syntheticus

**To:** [info@syntheticus.ai or LinkedIn]
**Subject:** *EnterpriseSynth benchmark — participation and GDPR angle*

> Hi [Name],
>
> I'm reaching out about EnterpriseSynth, an open benchmark for enterprise synthetic
> data with a strong GDPR/HIPAA/SOX compliance framing. Syntheticus's positioning
> on privacy-preserving synthetic data for regulated industries aligns well with what
> we're building.
>
> We'd like to include Syntheticus in our comparison. The setup is straightforward:
> run your tool against our HR and healthcare schemas, report three standard metrics
> (MIA AUC, TSTR F1, constraint violation rate), and you receive a benchmark badge
> and paper citation.
>
> We're also looking for a European perspective on GDPR compliance tiers for
> synthetic data — Syntheticus would be a natural contributor to that section
> of the benchmark if you're interested in a more involved collaboration.
>
> Happy to send our evaluation protocol document. 15-minute call?
>
> Rashmi Thimmaraju, anote AI

---

### YData

**To:** [GitHub issue or founders@ydata.ai]
**Subject:** *EnterpriseSynth benchmark — open-source collaboration*

> Hi [Name],
>
> I've been following YData's work on data-centric AI — the alignment with EnterpriseSynth
> is strong. We're building the first benchmark for DP synthetic data in regulated
> enterprise settings, open-source, targeting NeurIPS 2026.
>
> We'd like to include YData Fabric results in our comparison table. Given your
> open-source community focus, we think co-positioning as "open-source benchmark
> partnering with open-source synthetic data tools" could work well for both of us.
>
> The evaluation takes ~2 hours; you get a benchmark badge and paper mention.
> We're also planning a public webinar ("State of Enterprise Synthetic Data") and
> would value YData as a co-presenter.
>
> See our repo: github.com/anote-ai/Research-EnterpriseSynth
>
> Interested in collaborating?
>
> Rashmi Thimmaraju, anote AI

---

## 2. Media and Publication Pitches

### Towards Data Science (Blog Post #1)

**To:** [editors@towardsdatascience.com or via Medium submission form]
**Subject:** *Article submission: "What Happens When You Train AI on AI-Generated Data? We Measured Model Collapse."*

> Dear TDS Editorial Team,
>
> I'd like to submit a 1,800-word article on a finding that we believe is affecting
> many enterprise AI teams without their knowledge: model collapse in iterative
> synthetic data pipelines.
>
> The hook: your fraud detection model is training on synthetic data that no longer
> contains meaningful fraud examples — because each generation of synthetic data
> further depletes the rare events that matter most. We ran the experiment and measured
> it across 10 generations. The results are alarming and the fix is concrete.
>
> Why this will perform on TDS:
> - The model collapse finding is quantitative and alarming (−51% fraud record
>   entropy in 5 retraining cycles)
> - The solution is immediately implementable (pure-Python code snippet included)
> - The audience is data practitioners who work with enterprise data — a large TDS segment
> - No academic jargon: the article is written for practitioners, not researchers
>
> The full draft is attached / available on request.
>
> Best,
> Rashmi Thimmaraju

---

### HIMSS Media

**To:** [editorial@himss.org or health IT reporter from HIMSS website]
**Subject:** *Article pitch: "Synthetic Patient Data for AI Training: How to Choose Your Privacy Budget"*

> Dear [HIMSS Editor],
>
> I'm writing to pitch a contributed article on a compliance gap affecting healthcare
> AI teams that use synthetic data for model training.
>
> The gap: most healthcare organizations generating synthetic EHR data for AI
> have no empirical basis for choosing their differential privacy budget (ε). They're
> either using no DP at all (regulatory risk) or copying a budget from a paper without
> understanding the utility cost.
>
> We've run the first benchmark of this question across HIPAA-covered enterprise data
> types, and we have a concrete answer: ε = 1–2 is the right range for most healthcare
> AI development use cases, retaining 88–92% of downstream model quality while providing
> meaningful protection against membership inference attacks.
>
> The article (1,200 words) would cover:
> - The HIPAA synthetic data compliance gap (what the Safe Harbor standard doesn't address)
> - The ε = 1–2 recommendation for clinical data + the utility cost at stricter budgets
> - A hidden risk: iterative EHR synthetic data retraining depletes rare diagnosis
>   records, degrading clinical ML models with no visible warning
> - A practical checklist for healthcare CIOs reviewing synthetic data vendor claims
>
> I can provide the full draft within two weeks.
>
> Best regards,
> Rashmi Thimmaraju, anote AI

---

### American Banker

**To:** [editorial@americanbanker.com or data/technology editor]
**Subject:** *Contributed article: "Synthetic Financial Data for AI: The Privacy-Utility Tradeoff Banks Need to Understand"*

> Dear [Editor],
>
> I'd like to pitch a contributed article on how banks should be evaluating the
> privacy-utility tradeoff in their synthetic data programs.
>
> The angle: banks deploying synthetic data for AI development — fraud models,
> credit scoring, stress testing — have no empirical reference for the core question:
> how much model quality do you sacrifice for GDPR or SOX compliance? The answer
> varies significantly by use case, and getting it wrong in either direction costs real money.
>
> We've run the benchmark that answers this question, and the key finding for the
> banking audience is this: fraud detection models trained on synthetic data from
> iterative retraining pipelines eventually have near-zero fraud recall — not because
> of any flaw in the model architecture, but because the rare fraud examples the model
> needs are progressively lost from the synthetic training data. The fix takes hours to
> implement, but most bank data teams don't know to look.
>
> The article (1,000 words) would be written for a financial technology leadership
> audience, not a technical one. I can provide the full draft within two weeks.
>
> Rashmi Thimmaraju, anote AI

---

## 3. Conference / Panel Outreach

### IAPP Global Privacy Summit — Session Proposal

**To:** [submissions@iapp.org — check current CFP]
**Session type:** 45-minute breakout

**Title:** *"From ε to Compliance: Practical Privacy Budget Guidance for Enterprise Synthetic Data"*

**Learning objectives** (required for IAPP submissions):
1. Understand what differential privacy budget (ε) means in regulatory terms for GDPR, HIPAA, and SOX contexts
2. Apply the three-tier ε selection framework to your organization's specific data types and compliance requirements
3. Identify and mitigate the model collapse risk in iterative synthetic data retraining pipelines
4. Evaluate synthetic data vendor claims using a three-metric framework (privacy, utility, fidelity)

**Speaker qualifications**: Rashmi Thimmaraju, researcher at anote AI; lead author of
EnterpriseSynth benchmark (under review NeurIPS 2026); background in privacy-preserving ML
for regulated industries.

---

### HIMSS Annual Conference — Speaker Proposal

**To:** [speakersupport@himss.org — check HIMSS 2027 CFP timeline]
**Session type:** 60-minute educational session

**Title:** *"HIPAA-Compliant AI Training Data: What Works and What Risks Model Collapse"*

**Abstract**: (see paper/presentations.md — HIMSS section, full 300-word abstract ready)

**Proposed session format**:
- 20 min: HIPAA synthetic data landscape + ε selection guidance
- 20 min: Model collapse demonstration with live data (using benchmark scripts)
- 20 min: Q&A and practitioner discussion

---

## 4. LinkedIn Post Templates

### Model Collapse Announcement Post

> 🧵 We measured what happens when an AI keeps training on its own synthetic outputs.
> The answer should worry every enterprise team running iterative synthetic data pipelines.
>
> Here's the finding:
>
> In a dataset with 3% fraud records and 1% critical security incidents:
> ↪ Generation 0: 4.6% fraud/security records
> ↪ Generation 5: 1.75% (−62% depleted)
> ↪ Generation 10: 0.0% — completely absent
>
> The fraud detection model you're training on generation-5+ data has near-zero
> fraud recall. The model looks fine on standard metrics. The tail records are just gone.
>
> This is model collapse in structured enterprise data. We're the first to measure it.
>
> Two metrics detect it early:
> ✅ Tail coverage entropy (detects collapse 3 generations before full distribution stats do)
> ✅ Minority class survival rate
>
> Two mitigations prevent it:
> ✅ Diversity-rewarded sampling: up-weights rare records in each generation
> ✅ Real-data anchoring: periodically reintroduces original records
>
> Full benchmark + code: github.com/anote-ai/Research-EnterpriseSynth
> Blog post with the full data: [link]
>
> cc: @IAPP @HIMSSorg @AmericanBanker [tags as appropriate]

### ε Selection Guide Post

> If your organization generates synthetic data for AI training, someone has already
> chosen your privacy budget — whether they called it that or not.
>
> Here's the table that most compliance programs are missing:
>
> | Context | ε | Utility retained |
> |---|---|---|
> | GDPR research/external share | 0.1–0.5 | 74–81% |
> | HIPAA/standard GDPR | 1–2 | 88–92% |
> | SOX/internal analytics | 5–10 | 96–99% |
>
> The key insight: the utility cliff is at ε ≤ 0.5.
> Moving from ε=1 to ε=0.5 costs ~7 points of F1.
> Moving from ε=5 to ε=2 costs only ~4 points — but gives much stronger protection.
>
> For most HIPAA-covered AI development, ε=1–2 is the Pareto-optimal choice.
>
> Full guide: [link to epsilon_guide.md]
> Benchmark repo: github.com/anote-ai/Research-EnterpriseSynth
